enVVeno Medical Says It Received FDA IDE Approval For TAVVE Pivotal Study Of enVVe Replacement Venous Valve, Enrollment Of Approximately 230 Patients Expected To Begin In H2 2026
Share
Why It Matters
enVVeno Medical got permission from the FDA to test a new artificial vein valve in people starting later in 2026. This is a big step forward for the company, showing their invention passed early safety checks and they're moving toward proving it really works.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.